Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleCELLULAR AND MOLECULAR

α1B- and α1D-Adrenergic Receptors Exhibit Different Requirements for Agonist and Mitogen-Activated Protein Kinase Activation to Regulate Growth Responses in Rat 1 Fibroblasts

Bruce A. Waldrop, Diana Mastalerz, Michael T. Piascik and Ginell R. Post
Journal of Pharmacology and Experimental Therapeutics January 2002, 300 (1) 83-90; DOI: https://doi.org/10.1124/jpet.300.1.83
Bruce A. Waldrop
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Diana Mastalerz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael T. Piascik
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ginell R. Post
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

We compared DNA replication, protein biosynthesis, and mitogen-activated protein kinase (MAPK) activity in Rat 1 fibroblasts stably expressing either the α1B-adrenergic receptor (AR) or α1D-AR subtypes. Activation of both the α1B-AR and α1D-AR inhibited DNA synthesis (as assessed by [3H]thymidine incorporation). In contrast, both receptors stimulated protein biosynthesis (as measured by [35S]methionine incorporation) and activated extracellular signal-regulated kinase (ERK)1/2. Importantly, these responses were agonist-dependent for the α1B-AR, but were agonist-independent for the α1D-AR. Agonist activation of the α1B-AR resulted in increased p38 kinase activity, but not c-Jun NH2-terminal kinase (JNK) activity, whereas the α1D-AR activated JNK but not p38 kinase. Unlike ERK1/2, JNK activity was increased by agonist treatment in the α1D-AR cells. An ERK1/2-pathway inhibitor PD98059 had no effect on phenylephrine-mediated inhibition of DNA synthesis in either cell line but blocked protein biosynthesis mediated by both receptors. The p38 kinase inhibitor SB203580 blocked α1B-AR effects on [3H]thymidine and [35S]methionine incorporation in α1B-AR-expressing cells, but had no effect on α1D-AR-mediated growth responses, consistent with the inability of the α1D-AR to activate p38 kinase. Therefore, α1B- and α1D-ARs mediated similar growth responses but differ with respect to the MAPK family member involved and the requirement for agonist.

Footnotes

  • ↵1 Current Address: Bernard J. Dunn School of Pharmacy, Shenandoah University, 1460 University Dr., Winchester, VA 22601. E-mail: bwaldrop{at}su.edu

  • This study was supported by an American Heart Association Scientist Development grant and the University of Kentucky Medical Center Research Fund (to G.R.P.), American Foundation for Pharmaceutical Education predoctoral fellowship (to B.A.W.), National Institutes of Health HL-38120 (to M.T.P.), and American Heart Association Grant-in-Aid (to M.T.P. and G.R.P.).

  • Abbreviations

    AR
    adrenergic receptor
    MAPK
    mitogen-activated protein kinase
    ERK
    extracellular signal-regulated kinase
    JNK
    c-Jun NH2-terminal kinase
    DMEM
    Dulbecco's modified Eagle's medium
    FBS
    fetal bovine serum
    PE
    phenylephrine
    PBS
    phosphate-buffered saline
    GST
    glutathioneS-transferase
    MBP
    myelin basic protein
    IOD
    integrated optical density
    DMSO
    dimethyl sulfoxide
    PAGE
    polyacrylamide gel electrophoresis
    CHO
    Chinese hamster ovary
    SB
    SB203580
    • Received May 8, 2001.
    • Accepted June 20, 2001.
    • The American Society for Pharmacology and Experimental Therapeutics
    View Full Text

    JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

    Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

     

    • Click here for information on institutional subscriptions.
    • Click here for information on individual ASPET membership.

     

    Log in using your username and password

    Forgot your user name or password?

    Purchase access

    You may purchase access to this article. This will require you to create an account if you don't already have one.
    PreviousNext
    Back to top

    In this issue

    Journal of Pharmacology and Experimental Therapeutics: 300 (1)
    Journal of Pharmacology and Experimental Therapeutics
    Vol. 300, Issue 1
    1 Jan 2002
    • Table of Contents
    • About the Cover
    • Index by author
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

    NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

    Enter multiple addresses on separate lines or separate them with commas.
    α1B- and α1D-Adrenergic Receptors Exhibit Different Requirements for Agonist and Mitogen-Activated Protein Kinase Activation to Regulate Growth Responses in Rat 1 Fibroblasts
    (Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
    (Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Research ArticleCELLULAR AND MOLECULAR

    α1B- and α1D-Adrenergic Receptors Exhibit Different Requirements for Agonist and Mitogen-Activated Protein Kinase Activation to Regulate Growth Responses in Rat 1 Fibroblasts

    Bruce A. Waldrop, Diana Mastalerz, Michael T. Piascik and Ginell R. Post
    Journal of Pharmacology and Experimental Therapeutics January 1, 2002, 300 (1) 83-90; DOI: https://doi.org/10.1124/jpet.300.1.83

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    Research ArticleCELLULAR AND MOLECULAR

    α1B- and α1D-Adrenergic Receptors Exhibit Different Requirements for Agonist and Mitogen-Activated Protein Kinase Activation to Regulate Growth Responses in Rat 1 Fibroblasts

    Bruce A. Waldrop, Diana Mastalerz, Michael T. Piascik and Ginell R. Post
    Journal of Pharmacology and Experimental Therapeutics January 1, 2002, 300 (1) 83-90; DOI: https://doi.org/10.1124/jpet.300.1.83
    del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • Abstract
      • Materials and Methods
      • Results
      • Discussion
      • Acknowledgments
      • Footnotes
      • Abbreviations
      • References
    • Figures & Data
    • Info & Metrics
    • eLetters
    • PDF

    Related Articles

    Cited By...

    More in this TOC Section

    • CsA downregulates Selenop expression via a STAT3-FoxO1 axis
    • Anisodamine Ameliorates Acute Lung Injury
    • ACE2 Inhibits LPS-Caused Lung Fibrosis
    Show more Cellular and Molecular

    Similar Articles

    Advertisement
    • Home
    • Alerts
    Facebook   Twitter   LinkedIn   RSS

    Navigate

    • Current Issue
    • Fast Forward by date
    • Fast Forward by section
    • Latest Articles
    • Archive
    • Search for Articles
    • Feedback
    • ASPET

    More Information

    • About JPET
    • Editorial Board
    • Instructions to Authors
    • Submit a Manuscript
    • Customized Alerts
    • RSS Feeds
    • Subscriptions
    • Permissions
    • Terms & Conditions of Use

    ASPET's Other Journals

    • Drug Metabolism and Disposition
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    ISSN 1521-0103 (Online)

    Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics